Advertisement
UK markets close in 5 hours 18 minutes
  • FTSE 100

    8,117.39
    +38.53 (+0.48%)
     
  • FTSE 250

    19,833.47
    +231.49 (+1.18%)
     
  • AIM

    755.57
    +2.45 (+0.33%)
     
  • GBP/EUR

    1.1660
    +0.0003 (+0.03%)
     
  • GBP/USD

    1.2517
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    51,524.33
    +706.52 (+1.39%)
     
  • CMC Crypto 200

    1,389.86
    -6.67 (-0.48%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.95
    +0.38 (+0.45%)
     
  • GOLD FUTURES

    2,361.70
    +19.20 (+0.82%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,049.22
    +131.94 (+0.74%)
     
  • CAC 40

    8,041.58
    +24.93 (+0.31%)
     

Looking At Novartis AG (VTX:NOVN) From All Angles

Novartis AG (VTX:NOVN) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case of NOVN, it is a notable dividend payer that has been a rockstar for income investors, currently trading at an attractive share price. In the following section, I expand a bit more on these key aspects. For those interested in understanding where the figures come from and want to see the analysis, read the full report on Novartis here.

6 star dividend payer and good value

NOVN’s share price is trading at below its true value, meaning that the market sentiment for the stock is currently bearish. According to my intrinsic value of the stock, which is driven by analyst consensus forecast of NOVN’s earnings, investors now have the opportunity to buy into the stock to reap capital gains. Compared to the rest of the pharmaceuticals industry, NOVN is also trading below its peers, relative to earnings generated. This supports the theory that NOVN is potentially underpriced.

SWX:NOVN Intrinsic Value June 22nd 18
SWX:NOVN Intrinsic Value June 22nd 18

For those seeking income streams from their portfolio, NOVN is a robust dividend payer as well. Over the past decade, the company has consistently increased its dividend payout, reaching a yield of 3.80%, making it one of the best dividend companies in the market.

SWX:NOVN Historical Dividend Yield June 22nd 18
SWX:NOVN Historical Dividend Yield June 22nd 18

Next Steps:

For Novartis, there are three relevant aspects you should further examine:

ADVERTISEMENT
  1. Future Outlook: What are well-informed industry analysts predicting for NOVN’s future growth? Take a look at our free research report of analyst consensus for NOVN’s outlook.

  2. Historical Performance: What has NOVN’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.

  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of NOVN? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.